Page last updated: 2024-10-26

dilazep and Left Ventricular Hypertrophy

dilazep has been researched along with Left Ventricular Hypertrophy in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research Excerpts

ExcerptRelevanceReference
" We measured serum cardiac troponin T levels by the Elecsys troponin T assay and randomized 40 hemodialysis patients with left ventricular hypertrophy (LVH) into two treatment groups: a dilazep dihydrochloride group (300 mg/day, n = 20) and a placebo group (n = 20)."5.10Effect of dilazep dihydrochloride on serum cardiac troponin T levels in hemodialysis patients. ( Ebihara, I; Koide, H; Nakamura, T; Osada, S; Shimada, N; Takahashi, Y; Tanaka, A; Ugai, K; Ushiyama, C, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, T1
Ushiyama, C1
Osada, S1
Ugai, K1
Takahashi, Y1
Tanaka, A1
Shimada, N1
Ebihara, I1
Koide, H1

Trials

1 trial available for dilazep and Left Ventricular Hypertrophy

ArticleYear
Effect of dilazep dihydrochloride on serum cardiac troponin T levels in hemodialysis patients.
    Kidney & blood pressure research, 2002, Volume: 25, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Dilazep; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle

2002